Validated Antimalarial Drug Target Discovery using Genome-Scale Metabolic Modelling
Supannee Taweechai, Francis Isidore G. Totañes, David R. Westhead, Clara Herrera-Arozamena, Richard Foster, Glenn A. McConkey
This study validates a new antimalarial drug target using genome-scale metabolic modeling and experimental testing of inhibitors against Plasmodium falciparum UCK.
bioRxiv · Mar 26, 2025 · PreprintMicrobiology